Ottawa Hospital Research Institute
$1,205,636.00 CAD
- Department
- Canadian Space Agency
- Recipient country
- Canada
- Fiscal year
- 2025-2026
- Agreement period
- August 15, 2025 – March 31, 2031
- Reference
- csa-asc:003-2025-2026-Q2-00001
Published purpose
Astronauts return from space with anemia. The mechanisms causing anemia are not known. During long space missions to the Moon or Mars, astronaut must stay safe from severe anemia. The SPleen Activity in SPace Anemia (SPA2) aims to address outstanding questions on the mechanism of space anemia. SPA2 will test two (2) key hypotheses: 1) The spleen is altered by prolonged exposure to space; and 2) Space anemia is caused by extravascular hemolysis in the spleen. SPA2 will measure changes in spleen size, shape, and structure using magnetic resonance and ultrasonography. Then, SPA2 will measure hemolysis and hemolysis markers using comprehensive clinical and laboratory techniques.
Community tags
Tags are applied by readers, not by this site. One tag per person per record.